概括
目瘤学的最新进展改善了视网膜母细胞瘤和眼膜黑色素瘤等眼癌患者的生存率. 新的治疗方法旨在保护生命,眼睛和视力,为这些罕见的恶性瘤提供更好的治疗结果.
科学领域:
- 眼科医生 眼科 眼科
- 在瘤学瘤学.
背景情况:
- 恶性眼睛瘤虽然不常见,但会显著影响患者的生活和视力.
- 关键类型包括视网膜母细胞瘤 (儿科眼内瘤),脑膜黑色素瘤 (成人眼内瘤) 和眼基底细胞癌 (眼周瘤).
- 治疗的挑战包括控制眼内瘤的扩散和控制眼瘤侵入眼组织.
研究的目的:
- 审查过去十年眼部恶性瘤管理和治疗的最新进展.
- 专门针对结膜黑色素瘤治疗的最新进展,这是一种罕见而具有攻击性的眼癌.
主要方法:
- 关于眼睛瘤治疗进展的文献综述.
- 专注于局部和全身治疗策略.
- 对治疗结果和生存率的分析.
主要成果:
- 新型局部和全身治疗的出现改善了患者的生存率.
- 在保护眼睛和可能的视力方面取得了显著的进步.
- 改善了各种眼部癌症患者的整体生存率.
结论:
- 在过去的十年中,在治疗恶性眼瘤方面取得了重大进展.
- 新的治疗方法提高了拯救生命的潜力和眼睛/视觉的保存.
- 持续的研究对于管理罕见但致命的瘤,如结膜黑色素瘤至关重要.
相关概念视频
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:27Open Angle Glaucoma: Treatment
391
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
391
01:28Angle Closure Glaucoma: Treatment
435
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
435
01:27Tumor Immunotherapy
475
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
475
01:25Glaucoma: Overview
505
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
505